Krishnan Viswanadhan

Director, CARGO Therapeutics, Inc.

Companies

Agios PharmaceuticalsChief Corp Dev & Strategy Mar 7, 2025 to now¹
CARGO Therapeutics, Inc.Board member Nov 9, 2023 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Agios Pharmaceuticals AGIO10,282 shares³$353.3K at $34.36Apr 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 2, 2026Sold 2,959 shares at $34.71 of Agios Pharmaceuticals³
Apr 2, 2026Exercised options 8,100 shares of Agios Pharmaceuticals³
Mar 5, 2026Sold 2,959 shares at $27.80 of Agios Pharmaceuticals⁴
Mar 5, 2026Exercised options 8,100 shares of Agios Pharmaceuticals⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAgios Pharmaceuticals, Chief Corp Dev & Strategy
2
SEC EDGARCARGO Therapeutics, Inc., Board member
3
SEC EDGARAgios Pharmaceuticals shares after the filing of Apr 2, 2026
4
SEC EDGARForm 4 filed Mar 9, 2026